Cancer Therapy Targeting the HER2-PI3K Pathway: Potential Impact on the Heart

The HER2-PI3K pathway is the one of the most mutated pathways in cancer. Several drugs targeting the major kinases of this pathway have been approved by the Food and Drug Administration and many are being tested in clinical trials for the treatment of various cancers. However, the HER2-PI3K pathway...

Descripción completa

Detalles Bibliográficos
Autores principales: Klement, Giannoula L., Goukassian, David, Hlatky, Lynn, Carrozza, Joseph, Morgan, James P., Yan, Xinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2012
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384262/
https://www.ncbi.nlm.nih.gov/pubmed/22754526
http://dx.doi.org/10.3389/fphar.2012.00113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384262/
https://www.ncbi.nlm.nih.gov/pubmed/22754526
http://dx.doi.org/10.3389/fphar.2012.00113

Ejemplares similares